SPIA
HARP

Steward Partners Investment Advisory’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Steward Partners Investment Advisory’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23
Closed -$4.81K – 7492
2021
Q1 		$4.81K Buy
+23
New +$4.61K ﹤0.01% 3013

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Steward Partners Investment Advisory's HARP Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 23 shares — an estimated $4.81K sold.

Steward Partners Investment Advisory first reported a position in HARP in Q1 2021 and held it in 1 quarter. The position peaked at $4.81K in Q1 2021. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 23 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $4.81K.
  • Steward Partners Investment Advisory first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.81K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.